Bhartiya Shibal
Department of Ophthalmology, Glaucoma Services, Fortis Memorial Research Institute, Gurugram, Haryana, India.
J Curr Glaucoma Pract. 2020 May-Aug;14(2):68-71. doi: 10.5005/jp-journals-10078-1281.
The ultimate goal of glaucoma therapy, as of any other therapeutic intervention, is to achieve superior clinical outcomes, patient satisfaction, and patient adherence to treatment. In a chronic asymptomatic disease, such as, glaucoma, where diagnostic and therapeutic algorithms may have multiple acceptable treatment arms, patient centricity becomes increasingly important. Shared decision-making, patient participation, quality of life (QoL) concerns, and risk-benefit analyzes further complicate this decision-making. In addition, the ethics of research in glaucoma and also that of glaucoma screening may often be in conflict with the ethics of patient care. This article aims to highlight the ethical dilemmas that confound decision-making in current glaucoma practice, and the doctors' fiduciary duties to the patient. Bhartiya S. Patient Centricity and the Ethics of Glaucoma Care. J Curr Glaucoma Pract 2020;14(2):68-71.
与任何其他治疗干预一样，青光眼治疗的最终目标是取得卓越的临床效果、患者满意度以及患者对治疗的依从性。在青光眼这样一种慢性无症状疾病中，诊断和治疗方案可能有多个可接受的治疗分支，以患者为中心变得愈发重要。共同决策、患者参与、生活质量（QoL）问题以及风险效益分析使这一决策过程更加复杂。此外，青光眼研究的伦理以及青光眼筛查的伦理常常可能与患者护理的伦理相冲突。本文旨在突出当前青光眼治疗实践中困扰决策的伦理困境以及医生对患者的信托责任。 巴尔蒂亚·S. 以患者为中心与青光眼护理的伦理。《当代青光眼实践杂志》2020年；14(2):68 - 71。
